XML 69 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Receivables (Notes)
12 Months Ended
Dec. 31, 2013
Receivables [Abstract]  
Receivables [Text Block]
Receivables

We deliver a broad array of information technology and technical services solutions under contracts with the U.S. government, state and local governments and commercial customers. The components of contract receivables are as follows (in thousands):

 
December 31,
 
2013
 
2012
Billed receivables
$
370,975

 
$
420,598

Unbilled receivables:
 
 
 
Amounts billable
84,582

 
119,893

Revenues recorded in excess of funding
9,743

 
11,148

Retainage
2,634

 
6,119

Allowance for doubtful accounts
(10,036
)
 
(9,449
)
Receivables-net
$
457,898

 
$
548,309



Amounts billable consist principally of amounts to be billed within the next month. Revenues recorded in excess of funding are billable upon receipt of contractual amendments or other modifications. Revenues recorded in excess of milestone billings on fixed price contracts consist of amounts not expected to be billed within the next month. The retainage is billable upon completion of the contract performance and approval of final indirect expense rates by the government. There is a contract with the U.S. Army that represents 15.3% of receivables-net at December 31, 2013 and multiple contracts with the U.S. Army that represent 28.0% of receivables-net at December 31, 2012. Accounts receivable at December 31, 2013 are expected to be substantially collected within one year except for approximately $1.5 million, of which 91.2% is related to receivables from sales to the U.S. government. The remainder is related to receivables from contracts in which we acted as a subcontractor to other contractors.

The Company does not believe it has significant exposure to credit risk as accounts receivable and the related unbilled amounts are primarily due from the U.S. government. The allowance for doubtful accounts represents our estimate for exposure to compliance, contractual issues and bad debts related to prime contractors.